Status:
RECRUITING
Acoustic Waveform Respiratory Evaluation
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
University of Pittsburgh
Conditions:
Asthma
COPD
Eligibility:
All Genders
8-70 years
Phase:
NA
Brief Summary
The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify di...
Detailed Description
Asthma and COPD respectively affect millions of people in the US. Chronic lower respiratory diseases represented the fourth leading cause of death in the country before the pandemic. For these and oth...
Eligibility Criteria
Inclusion
- Age 8-70 years
- Ability to perform spirometry and oscillometry
- Signed informed consent (and assent for children as appropriate)
- No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases
Exclusion
- Inability or unwillingness to perform AWARE, spirometry, or oscillometry
- Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS)
Key Trial Info
Start Date :
July 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2029
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06512064
Start Date
July 23 2024
End Date
April 1 2029
Last Update
October 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University
Indianapolis, Indiana, United States, 46202
2
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15224